Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation & Amortization (CF) (2016 - 2025)

China Pharma Holdings filings provide 16 years of Depreciation & Amortization (CF) readings, the most recent being $497425.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 11.01% to $497425.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 42.57% decrease, with the full-year FY2025 number at $1.5 million, down 42.57% from a year prior.
  • Depreciation & Amortization (CF) hit $497425.0 in Q4 2025 for China Pharma Holdings, up from $356034.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $976457.0 in Q3 2021 to a low of $320863.0 in Q2 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $689028.0 (2022), compared with a mean of $633185.4.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 45.03% in 2021 and later crashed 56.6% in 2025.
  • China Pharma Holdings' Depreciation & Amortization (CF) stood at $710716.0 in 2021, then fell by 10.03% to $639425.0 in 2022, then rose by 8.82% to $695835.0 in 2023, then plummeted by 35.61% to $448073.0 in 2024, then increased by 11.01% to $497425.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $497425.0 (Q4 2025), $356034.0 (Q3 2025), and $320863.0 (Q2 2025) per Business Quant data.